PRDM9 and Alzheimer disease: A marker of gene silencing—increased trimethylation of lysine 9 in histone H3 (H3K9) [37]—as well as higher levels of histone methyltransferase EHMT1 mRNA were also observed in the post mortem brain of AD subjects [38].